The multi-CDK inhibitor dinaciclib reverses bromo- and extra-terminal domain (BET) inhibitor resistance in acute myeloid leukemia via inhibition of Wnt/β-catenin signaling
多 CDK 抑制剂 dinaciclib 通过抑制 Wnt/β-catenin 信号传导逆转急性髓系白血病中溴和额外末端结构域 (BET) 抑制剂的耐药性
期刊:Experimental Hematology & Oncology
影响因子:9.4
doi:10.1186/s40164-024-00483-w
Alexander R Marr, Madeline Halpin, Dominique L Corbin, Yerdanos Asemelash, Steven Sher, Britten K Gordon, Ethan C Whipp, Shaneice Mitchell, Bonnie K Harrington, Shelley Orwick, Samon Benrashid, Virginia M Goettl, Vedat Yildiz, Andrew D Mitchell, Olivia Cahn, Alice S Mims, Karilyn T M Larkin, Meixao
